全文获取类型
收费全文 | 875篇 |
免费 | 58篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 19篇 |
妇产科学 | 7篇 |
基础医学 | 134篇 |
口腔科学 | 12篇 |
临床医学 | 64篇 |
内科学 | 249篇 |
皮肤病学 | 7篇 |
神经病学 | 47篇 |
特种医学 | 18篇 |
外科学 | 126篇 |
综合类 | 24篇 |
预防医学 | 69篇 |
眼科学 | 7篇 |
药学 | 85篇 |
中国医学 | 6篇 |
肿瘤学 | 61篇 |
出版年
2024年 | 3篇 |
2023年 | 12篇 |
2022年 | 26篇 |
2021年 | 47篇 |
2020年 | 25篇 |
2019年 | 32篇 |
2018年 | 39篇 |
2017年 | 25篇 |
2016年 | 34篇 |
2015年 | 30篇 |
2014年 | 31篇 |
2013年 | 38篇 |
2012年 | 66篇 |
2011年 | 67篇 |
2010年 | 51篇 |
2009年 | 30篇 |
2008年 | 46篇 |
2007年 | 62篇 |
2006年 | 42篇 |
2005年 | 50篇 |
2004年 | 40篇 |
2003年 | 29篇 |
2002年 | 27篇 |
2001年 | 11篇 |
2000年 | 11篇 |
1999年 | 13篇 |
1998年 | 10篇 |
1997年 | 2篇 |
1996年 | 7篇 |
1995年 | 2篇 |
1994年 | 6篇 |
1993年 | 5篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1990年 | 4篇 |
1989年 | 5篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1984年 | 1篇 |
1983年 | 3篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1974年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有944条查询结果,搜索用时 15 毫秒
51.
Ghotloo Somayeh Amiri Mohammad Mehdi Khoshnoodi Jalal Abbasi Ebrahim Jeddi-Tehrani Mahmood Golsaz-Shirazi Forough Shokri Fazel 《Neurotoxicity research》2020,37(3):578-586
Neurotoxicity Research - Monoclonal antibodies (MAbs) against neurotoxin of Clostridium tetani are considered as a novel source of immunoglobulins for passive immunotherapy of tetanus. Toxin... 相似文献
52.
53.
Sami Asfar Jassim Al-Ali Hussein Safar Marzouk Al-Bader Emad Farid Ahmad Ali Jalal Kansou 《Acta chirurgica》2002,168(11):626-630
OBJECTIVES: To audit the management of vascular trauma in Kuwait, 1992-2000. DESIGN: Retrospective open study. SETTING: Vascular surgery unit, teaching hospital, Kuwait. SUBJECTS: 155 patients with vascular injuries, most of which (n = 118) involved the extremities. 21 had neck injuries, 10 abdominal, and 6 chest. INTERVENTION: Revascularisation usually using the long saphenous vein in addition to direct repair or end-to-end anastomosis. MAIN OUTCOME: Morbidity (amputation) and mortality. RESULTS: Four lower limb grafts failed, two of which (2/69, 3%) required amputation. Overall, four patients died (3%), one of pulmonary embolism and 3 of severe injuries to major abdominal vessels. 3/10 patients with abdominal vascular trauma died. Mean (SD) follow up period was 4.4 (2) years. CONCLUSIONS: Civilian violence has increased in Kuwait. Vascular trauma to abdominal vessels is associated with high mortality. Autogenous saphenous vein forms an excellent conduit for revascularisation. 相似文献
54.
55.
Gholam Reza Raissi Fatemeh Ghazaei Bijan Forogh Seyed Pezhman Madani Abbas Daghaghzadeh Tannaz Ahadi 《Ultrasound in medicine & biology》2017,43(2):453-460
This study examined the effectiveness of radial extracorporeal shock wave therapy in the treatment of carpal tunnel syndrome (CTS). Forty patients with mild to moderate CTS were allocated to two groups: (i) shock wave + wrist splint and (ii) wrist splint. Patients used wrist splints followed by three sessions of low-energy shock wave therapy in the intervention group and wrist splints alone in the other group. The QuickDASH Questionnaire, visual analogue scale and nerve conduction studies were used to evaluate the patients before the study and at 3, 8 and 12 wk after the start of the treatment. At the end of the study, both groups saw the same clinical benefits. However, a significantly greater improvement in the median nerve distal sensory latency was noted in the shock wave group compared with the control group. We suggest that application of shock wave with alternative protocols may be effective in the treatment of CTS in future studies. 相似文献
56.
Research has shown that brain regions mediating disgust (e.g., the insula) become activated when viewing others’ disgust, a response mediated, perhaps by the mirror neuron system or the Theory of Mind module. In a novel behavioral experiment, we explore vicarious disgust and relief, in individuals with obsessive–compulsive disorder (OCD) symptoms. Participants (N = 10) provided disgust ratings to self-contamination or watching the contamination of an experimenter; and to the experimenter washing his own hands after the subjects had been contaminated. To our surprise, we found that subjects experienced disgust from merely watching the experimenter contaminating himself. More intriguingly, after subjects had contaminated themselves, they obtained relief from merely watching the experimenter washing his own hands; even while recognizing the logical absurdity of this. The result is counterintuitive since neither the subjects nor anyone else would have predicted this. These preliminary findings – if confirmed in placebo-controlled studies – might pave the way toward novel therapeutic approaches for OCD. 相似文献
57.
Mohammad Shahi M Rashidi MR Mahboob S Haidari F Rashidi B Hanaee J 《Rheumatology international》2012,32(8):2407-2414
To evaluate preventive and therapeutic effects of soy protein on collagen-induced arthritis rats. Sprague–Dawley rats immunized with bovine type II collagen emulsified in adjuvant and treated with soy protein (7?g/kg), dexamethasone (1?mg/kg), and casein (in control groups) by daily gavages feedings for 30?days. Score of arthritis recorded every day for each paws of animal. Tumor necrosis factor-alpha, interleukin6, leptin, and adiponectin were measured in serums. Treatment with soy protein resulted in significant delay in time to onset of arthritis as well as significantly decreased arthritis incidence, clinical arthritis severity score, histopathological arthritis severity score, and in vivo cell-mediated immunity to collagen (P?<?0.05). Administration of soy protein significantly suppressed the progression of collagen II-induced arthritis and inhibited the production of tumor necrosis factor-alpha, interleukin6, leptin, and adiponectin. Soy protein appeared to be a potent immunomodulatory inhibitor of collagen II-induced arthritis in rats. It could delay onset of RA and reduced cartilage erosion and synovitis inflammation. Therefore, it may be a useful protein in the prevention and treatment of rheumatoid arthritis patient. 相似文献
58.
59.
Dr Jalal K. Ghali S. William Tam Keith C. Ferdinand JoAnn Lindenfeld Michael L. Sabolinski Anne L. Taylor Manuel Worcel Charles L. Curry Jay N. Cohn 《Am J Cardiovasc Drugs》2007,7(5):373-380
BACKGROUND: In the A-HeFT (African-American Heart Failure Trial), treatment of African-American patients with New York Heart Association (NYHA) class III/IV heart failure (HF) with fixed-dose combination (FDC) of isosorbide dinitrate/hydralazine (I/H) reduced mortality and morbidity and improved patient reported functional status compared with standard therapy alone. OBJECTIVE: To examine the benefit of FDC I/H in subgroups based on baseline drug therapy and to investigate whether ACE inhibitors and/or angiotensin receptor antagonists (angiotensin receptor blockers) [ARBs] or beta-adrenoceptor antagonists (beta-blockers) provided additional benefit in FDC I/H-treated African-American patients with HF. STUDY DESIGN: The A-HeFT was a double-blind, placebo-controlled study enrolling 1050 patients stabilized on optimal HF therapies and with NYHA class III/IV HF with systolic dysfunction conducted during the years 2001-4 with up to 18 months follow-up. The primary endpoint was a composite of mortality, first HF hospitalization, and improvement of quality of life at 6 months. Secondary endpoints included mortality, hospitalizations, and change in quality of life. Prospective Kaplan-Meier survival analyses were used for differences between FDC I/H and placebo groups and retrospective analyses were conducted within FDC I/H-treated and placebo groups. RESULTS: Subgroup analysis for mortality, event-free survival (death or first HF hospitalization), and HF hospitalization showed that FDC I/H, compared with placebo, was effective with or without ACE inhibitors or beta-blockers or other standard medications with all-point estimates favoring the FDC I/H group. Within the placebo-treated group, beta-blockers or ACE inhibitors and/or ARBs were efficacious in improving survival (hazard ratio [HR] 0.33; p<0.0001 for [beta]-blocker use and HR 0.39; p=0.01 for ACE inhibitor and/or ARB use). However, within the FDC I/H-treated group, use of beta-blockers, but not ACE inhibitors and/or ARBs, provided additional significant benefit for survival (HR 0.44; p=0.029 and HR 0.60; p=0.34, respectively), event-free survival (HR 0.62; p=0.034 and HR 0.72; p=0.29, respectively) and the composite score of death, HF hospitalization and change in quality of life (p=0.016 and p=0.13, respectively). CONCLUSION: Based on the analysis of baseline medication use in the A-HeFT, FDC I/H was superior to placebo with or without beta-blockers or ACE inhibitor. However, beta-blockers but not ACE inhibitors and/or ARBs provided additional significant benefit in African-Americans with HF treated with FDC I/H. These analyses are hypotheses generating and their confirmation in clinical trials needs to be considered. 相似文献
60.